Across TCGA pan-cancer cohorts, RNU6-91P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RNU6-91P’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RNU6-91P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-91P is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.
HNSC are the cancer types where RNU6-91P tumor–normal differential expression is most reproducible.